tradingkey.logo

MoonLake Immunotherapeutics

MLTX

53.350USD

+0.430+0.81%
Market hours ETQuotes delayed by 15 min
3.39BMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-155.14%-38.14M
-292.68%-48.47M
-173.22%-25.27M
-129.38%-27.89M
-65.64%-14.95M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
-55.61%-11.60M
-363.27%-9.35M
---20.76M
---14.19M
---7.45M
---2.02M
Net income from continuing operations
-190.21%-40.56M
-488.23%-46.40M
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
-15.01%-16.47M
-134.44%-14.74M
---17.42M
---15.88M
---14.32M
---6.29M
Operating gains losses
1556.95%378.00K
39464.88%1.30M
888.30%32.52K
754.73%28.11K
593.40%22.81K
0.00%3.29K
-0.09%3.29K
0.03%3.29K
32.23%3.29K
32.25%3.29K
45.00%3.29K
--3.29K
--2.49K
--2.49K
--2.27K
Other non-cash items
-29.98%120.00K
-399.35%-1.41M
1060.88%681.80K
812.16%333.20K
276.36%171.38K
213.85%471.72K
-242.21%-70.96K
-151.80%-46.79K
-44.44%45.53K
276.93%150.30K
-67.94%49.89K
--90.33K
--81.96K
---84.95K
--155.63K
Change in working capital
87.03%-369.00K
40.33%-3.90M
719.43%8.28M
-322.45%-5.32M
-600.27%-2.84M
-408.10%-6.54M
-63.27%1.01M
78.73%-1.26M
249.96%568.55K
111.80%2.12M
21.99%2.75M
---5.92M
---379.14K
--1.00M
--2.26M
-Change in receivables
66.74%-146.00K
-29.76%-436.14K
-623.10%-730.25K
25.02%-180.94K
-172.15%-439.01K
-187.66%-336.11K
-132.22%-100.99K
-1083.98%-241.32K
62.73%-161.32K
567.77%383.41K
22.39%-43.49K
--24.52K
---432.80K
---81.96K
---56.03K
-Change in prepaid expenses
132.79%273.00K
25.59%-5.37M
128.53%1.49M
-824.40%-8.18M
-175.44%-832.51K
-2507.34%-7.22M
2.62%650.10K
68.59%-884.52K
230.15%1.10M
121.33%299.73K
37766.59%633.51K
---2.82M
---847.95K
---1.41M
--1.67K
-Change in other current assets
-31096.03%-1.70M
100.00%-2.00
--1.00
---1.00
---5.44K
---65.51K
----
----
----
----
----
----
----
----
----
-Change in other current liabilities
83.15%3.01M
-9.64%-1.72M
682.89%5.57M
211.74%1.66M
-53.95%1.65M
-95.57%-1.57M
-460.19%-955.20K
117.60%532.52K
58.97%3.57M
-199.32%-801.28K
24.34%265.19K
---3.03M
--2.25M
--806.74K
--213.28K
Cash from non-recurring investing activities
Cash from operating activities
-155.14%-38.14M
-292.68%-48.47M
-173.22%-25.27M
-129.38%-27.89M
-65.64%-14.95M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
-55.61%-11.60M
-363.27%-9.35M
---20.76M
---14.19M
---7.45M
---2.02M
Investing cash flow
Net cash from continuing investing activities
-83.47%35.00K
-38.32%175.57K
--132.19K
--0.00
--211.76K
28463300.00%284.63K
--0.00
100.00%0.00
-100.00%0.00
-99.99%1.00
-100.00%0.00
---2.00
--16.01K
--18.38K
--11.65K
Capital expenditures
-83.47%35.00K
-38.32%175.57K
--132.19K
--0.00
--211.76K
28463300.00%284.63K
--0.00
--0.00
-100.00%0.00
-99.99%1.00
-100.00%0.00
----
--16.01K
--18.38K
--11.65K
Net cash flow from disposal of fixed assets
-83.47%35.00K
-38.32%175.57K
--132.19K
--0.00
--211.76K
28463300.00%284.63K
--0.00
100.00%0.00
-100.00%0.00
-99.99%1.00
-100.00%0.00
---2.00
--16.01K
--18.38K
--11.65K
Net cash flow from investment products
296.84%56.28M
-225.61%-147.16M
133.50%58.41M
-792.19%-87.74M
-245.52%-28.59M
1083.17%117.15M
-312.96%-174.38M
--12.68M
--19.65M
--9.90M
---42.23M
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
295.27%56.25M
-226.07%-147.33M
133.42%58.28M
-792.19%-87.74M
-246.60%-28.80M
1080.30%116.87M
-312.96%-174.38M
633802550.00%12.68M
122826.62%19.65M
53976.58%9.90M
-362386.24%-42.23M
--2.00
---16.01K
---18.38K
---11.65K
Financing cash flow
Cash flow from continuous financing activities
43.44%73.12M
-99.47%150.71K
--183.10K
-100.00%0.00
--50.98M
749475.71%28.42M
--0.00
331.09%451.29M
-100.00%0.00
-99.97%3.79K
-100.00%0.00
--104.69M
--15.00M
--15.00M
--498.33K
Net cash flow from debt Issuance/repayment
--73.02M
----
----
----
----
--0.00
--0.00
----
-100.00%0.00
-100.00%0.00
--0.00
----
--15.00M
--15.00M
--0.00
Net cash flow from common stock issuance/repurchase
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--52.54M
822092.90%31.17M
--0.00
----
-100.00%0.00
162.22%3.79K
-100.00%0.00
----
--3.79K
---6.09K
--3.28K
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
----
--4.89K
--495.05K
Proceeds from stock option exercised by employees
200100.00%100.00K
--150.71K
--91.30K
--0.00
---50.00
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
100.00%0.00
100.00%0.00
--91.80K
--0.00
---1.56M
---2.75M
--0.00
----
----
100.00%0.00
--0.00
----
----
---1.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
43.44%73.12M
-99.47%150.71K
--183.10K
-100.00%0.00
--50.98M
749475.71%28.42M
--0.00
331.09%451.29M
-100.00%0.00
-99.97%3.79K
-100.00%0.00
--104.69M
--15.00M
--15.00M
--498.33K
Net cash flow
Beginning cash balance
-60.01%180.43M
18.07%375.66M
-31.69%342.79M
814.52%458.44M
1042.04%451.17M
672.16%318.17M
441.26%501.79M
467.45%50.13M
391.43%39.51M
8018.17%41.20M
4443.42%92.71M
--8.83M
--8.04M
--507.56K
--2.04M
Current period cash flow changes
1153.35%91.14M
-246.79%-195.23M
117.90%32.87M
-125.61%-115.65M
-31.55%7.27M
7928.16%133.00M
-256.52%-183.62M
438.50%451.66M
1235.77%10.62M
-122.56%-1.70M
-3259.80%-51.50M
--83.87M
--795.31K
--7.53M
---1.53M
Effect of exchange rate changes
-289.35%-88.00K
554.67%423.83K
-6600.94%-325.44K
88.30%-16.90K
8786.92%46.48K
881.32%64.74K
-93.26%5.01K
-183.38%-144.52K
91.77%-535.00
-387.91%-8.29K
7495.82%74.33K
---51.00K
---6.50K
--2.88K
---1.00K
Ending cash balance
-40.76%271.57M
-60.01%180.43M
18.07%375.66M
-31.69%342.79M
814.52%458.44M
1042.04%451.17M
672.16%318.17M
441.26%501.79M
467.45%50.13M
391.43%39.51M
8018.17%41.20M
--92.71M
--8.83M
--8.04M
--507.56K
Free cash flow
-151.81%-38.17M
-285.22%-48.65M
-174.65%-25.41M
-129.38%-27.89M
-67.99%-15.16M
-8.91%-12.63M
1.08%-9.25M
---12.16M
36.46%-9.02M
-55.23%-11.60M
-360.61%-9.35M
----
---14.20M
---7.47M
---2.03M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
KeyAI